TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06707103: Tissue Repair Gel in Venous Leg Ulcers in AU/US

Sponsor: TR Therapeutics · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 312 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$565,728

Rescue Site Savings

+$377,152

Unlock Full NCT06707103 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06707103 Rescue Dossier →